Friedhoff; Lawrence Tim

Patent Applications and Registrations

Patent applications and USPTO patent grants for Friedhoff; Lawrence Tim.The latest application filed is for "diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease".

Company Profile

6.3.12

Friedhoff; Lawrence Tim - Rivervale NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT.sub.2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease Grant 11,304,932 - Friedhoff , et al. April 19, 2	2022-04-19
Diaryl And Arylheteroaryl Urea Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Prophylaxis And Treatment Of Hallucinations Associated With A Neurodegenerative Disease App 20210177804 - FRIEDHOFF; Lawrence Tim ; et al.	2021-06-17
Use Of 5ht2a Inverse Agonists For Treating Psychosis App 20210128528 - FRIEDHOFF; Lawrence Tim ; et al.	2021-05-06
Diaryl And Arylheteroaryl Urea Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Prophylaxis And Treatment Of Rem Sleep Behavior Disorder App 20200397754 - FRIEDHOFF; Lawrence Tim ; et al.	2020-12-24
Diaryl And Arylheteroaryl Urea Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Prophylaxis And Treatme App 20190160043 - FRIEDHOFF; Lawrence Tim ; et al.	2019-05-30
Diaryl And Arylheteroaryl Urea Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Prophylaxis And Treatme App 20190151287 - FRIEDHOFF; Lawrence Tim ; et al.	2019-05-23
Methods Of Treating A Neurodegenerative Disease App 20190111052 - FRIEDHOFF; Lawrence Tim ; et al.	2019-04-18
Use Of 5ht2a Inverse Agonists For Treating Psychosis App 20190046506 - FRIEDHOFF; Lawrence Tim ; et al.	2019-02-14
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease Grant 10,034,859 - Friedhoff , et al. July 31, 2	2018-07-31
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder Grant 10,022,355 - Friedhoff , et al. July 17, 2	2018-07-17
Methods Of Improving Balance, Gait Or Both In Patients With Neurological Disease App 20170246163 - RAMASWAMY; Shankar ; et al.	2017-08-31
Diaryl And Arylheteroaryl Urea Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Prophylaxis And Treatment Of Hallucinations Associated With A Neurodegenerative Disease App 20170014385 - FRIEDHOFF; Lawrence Tim ; et al.	2017-01-19
Diaryl And Arylheteroaryl Urea Derivatives As Modulators Of The 5-ht2a Serotonin Receptor Useful For The Prophylaxis And Treatment Of Rem Sleep Behavior Disorder App 20160361296 - FRIEDHOFF; Lawrence Tim ; et al.	2016-12-15
Compositions And Methods Of Treating A Neurodegenerative Disease App 20160324852 - FRIEDHOFF; Lawrence Tim ; et al.	2016-11-10
Methods Of Treating A Neurodegenerative Disease App 20160324851 - FRIEDHOFF; Lawrence Tim ; et al.	2016-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.